Skip to content

Opening book details…

About this Medicine article

A Randomized Controlled Trial of Adjuvant Immunotherapy (Murine Monoclonal Antibody 494/32) in Resectable Pancreatic Cancer by Markus Büchler; Helmut Friess; Karl-Heinz Schultheiss; Christoph Gebhardt; Robert Kübel; Karl-Heinz Muhrer; Martin Winkelmann; Theo Wagener; Rainer Klapdor; Martin Kaul; Günther Müller; Gregor Schulz; Hans G. Beger is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Markus Büchler; Helmut Friess; Karl-Heinz Schultheiss; Christoph Gebhardt; Robert Kübel; Karl-Heinz Muhrer; Martin Winkelmann; Theo Wagener; Rainer Klapdor; Martin Kaul; Günther Müller; Gregor Schulz; Hans G. Beger
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)
Published
1991
Field
Medicine (Health Sciences)

More by Markus Büchler; Helmut Friess; Karl-Heinz Schultheiss; Christoph Gebhardt; Robert Kübel; Karl-Heinz Muhrer; Martin Winkelmann; Theo Wagener; Rainer Klapdor; Martin Kaul; Günther Müller; Gregor Schulz; Hans G. Beger

Browse all works by Markus Büchler; Helmut Friess; Karl-Heinz Schultheiss; Christoph Gebhardt; Robert Kübel; Karl-Heinz Muhrer; Martin Winkelmann; Theo Wagener; Rainer Klapdor; Martin Kaul; Günther Müller; Gregor Schulz; Hans G. Beger